Eli Lilly and Company is a
prestigious company university
established in 1876 in United States. It is represented
by 240 scientists in the AD Scientific Index. The
university’s scientists are particularly concentrated in
Natural Sciences (62 scientists), Medical and Health Sciences (55 scientists), and Engineering & Technology (13 scientists).
* Total H Index Rankings
Ranking Based
On Selection :1
PBPK Models
DDI
CYPs
H-Index Metrics
Total
Last 6 Years
Last 6 Years / Total
78
38
0.487
* Total H Index Rankings
Ranking Based
On Selection :2
GI cancer
translational research
lung cancer
phase 1 trials
H-Index Metrics
Total
Last 6 Years
Last 6 Years / Total
74
41
0.554
* Total H Index Rankings
Ranking Based
On Selection :3
H-Index Metrics
Total
Last 6 Years
Last 6 Years / Total
63
39
0.619
* Total H Index Rankings
Ranking Based
On Selection :4
Neurodegeneration
Neuroscience
H-Index Metrics
Total
Last 6 Years
Last 6 Years / Total
61
33
0.541
* Total H Index Rankings
Ranking Based
On Selection :5
Alzheimer's disease
Neurodegeneration
Drug discovery
H-Index Metrics
Total
Last 6 Years
Last 6 Years / Total
60
37
0.617
* Total H Index Rankings
Ranking Based
On Selection :6
Osteoporosis
Migraine
Cardiovascular Disease
Drug Development
H-Index Metrics
Total
Last 6 Years
Last 6 Years / Total
55
36
0.655
* Total H Index Rankings
Ranking Based
On Selection :7
H-Index Metrics
Total
Last 6 Years
Last 6 Years / Total
48
20
0.417
* Total H Index Rankings
Ranking Based
On Selection :8
Heart disease
inflammation
diabetes
noncoding RNAs
systems biology
H-Index Metrics
Total
Last 6 Years
Last 6 Years / Total
44
32
0.727
* Total H Index Rankings
Ranking Based
On Selection :9
Lipoprotein Metabolism and Atherosclerosis
H-Index Metrics
Total
Last 6 Years
Last 6 Years / Total
44
27
0.614
* Total H Index Rankings
Ranking Based
On Selection :10
Cancer
H-Index Metrics
Total
Last 6 Years
Last 6 Years / Total
43
23
0.535
* Total H Index Rankings
Ranking Based
On Selection :11
H-Index Metrics
Total
Last 6 Years
Last 6 Years / Total
42
28
0.667
* Total H Index Rankings
Ranking Based
On Selection :12
diabetes
cardiovascular diseases
osteoporosis
H-Index Metrics
Total
Last 6 Years
Last 6 Years / Total
41
26
0.634
* Total H Index Rankings
Ranking Based
On Selection :13
Clinical research
patients
methodology
effectiveness
cost-effectiveness
H-Index Metrics
Total
Last 6 Years
Last 6 Years / Total
41
20
0.488
* Total H Index Rankings
Ranking Based
On Selection :14
RNA
Oligonucleotides
Delivery of Novel Modalities
Virology
SARS-CoV-2
H-Index Metrics
Total
Last 6 Years
Last 6 Years / Total
40
34
0.850
* Total H Index Rankings
Ranking Based
On Selection :15
Clinical Trials
Inflammatory Bowel Disease
H-Index Metrics
Total
Last 6 Years
Last 6 Years / Total
37
23
0.622
* Total H Index Rankings
Ranking Based
On Selection :16
H-Index Metrics
Total
Last 6 Years
Last 6 Years / Total
35
23
0.657
* Total H Index Rankings
Ranking Based
On Selection :17
Health Outcomes
Real World Evidence
Pain
H-Index Metrics
Total
Last 6 Years
Last 6 Years / Total
34
23
0.676
* Total H Index Rankings
Ranking Based
On Selection :18
Diabetes
H-Index Metrics
Total
Last 6 Years
Last 6 Years / Total
33
25
0.758
* Total H Index Rankings
Ranking Based
On Selection :19
innate immunity
neuroimmunology
neurodegneration
pathagen/damage associated molecular patterns
host-pathogen interaction
H-Index Metrics
Total
Last 6 Years
Last 6 Years / Total
32
25
0.781
* Total H Index Rankings
Ranking Based
On Selection :20
H-Index Metrics
Total
Last 6 Years
Last 6 Years / Total
32
14
0.438
* Total H Index Rankings
Ranking Based
On Selection :21
osteopetrosis
psoriatic arthritis
rheumatoid arthritis
muscle
osteoarthrtis
H-Index Metrics
Total
Last 6 Years
Last 6 Years / Total
31
20
0.645
* Total H Index Rankings
Ranking Based
On Selection :22
H-Index Metrics
Total
Last 6 Years
Last 6 Years / Total
31
18
0.581
* Total H Index Rankings
Ranking Based
On Selection :23
Cardiometabolic Endocrinology
GLP-1RA
Obesity
NASH
H-Index Metrics
Total
Last 6 Years
Last 6 Years / Total
27
21
0.778
* Total H Index Rankings
Ranking Based
On Selection :24
H-Index Metrics
Total
Last 6 Years
Last 6 Years / Total
27
18
0.667
* Total H Index Rankings
Ranking Based
On Selection :25
Diabetes Obesity and Complications
H-Index Metrics
Total
Last 6 Years
Last 6 Years / Total
27
18
0.667
Stephen Hall
Eli Lilly and Company
Indianapolis, United States
H-Index Metrics
Total
Last 6 Years
Last 6 Years / Total
78
38
0.487
David R Ferry
Eli Lilly and Company
Indianapolis, United States
H-Index Metrics
Total
Last 6 Years
Last 6 Years / Total
74
41
0.554
Eswar Krishnan
Eli Lilly and Company
Indianapolis, United States
H-Index Metrics
Total
Last 6 Years
Last 6 Years / Total
63
39
0.619
Michael O'Neill
Eli Lilly and Company
Indianapolis, United States
H-Index Metrics
Total
Last 6 Years
Last 6 Years / Total
61
33
0.541
Martin Citron
Eli Lilly and Company
Indianapolis, United States
H-Index Metrics
Total
Last 6 Years
Last 6 Years / Total
60
37
0.617
JH Krege
Eli Lilly and Company
Indianapolis, United States
H-Index Metrics
Total
Last 6 Years
Last 6 Years / Total
55
36
0.655
Jonathan A Lee
Eli Lilly and Company
Indianapolis, United States
H-Index Metrics
Total
Last 6 Years
Last 6 Years / Total
48
20
0.417
Scot J Matkovich
Eli Lilly and Company
Indianapolis, United States
H-Index Metrics
Total
Last 6 Years
Last 6 Years / Total
44
32
0.727
Heart disease
inflammation
diabetes
noncoding RNAs
systems biology
Giacomo Ruotolo
Eli Lilly and Company
Indianapolis, United States
H-Index Metrics
Total
Last 6 Years
Last 6 Years / Total
44
27
0.614
Louis F Stancato
Eli Lilly and Company
Indianapolis, United States
H-Index Metrics
Total
Last 6 Years
Last 6 Years / Total
43
23
0.535
David H Adams
Eli Lilly and Company
Indianapolis, United States
H-Index Metrics
Total
Last 6 Years
Last 6 Years / Total
42
28
0.667
Imre Pavo
Eli Lilly and Company
Indianapolis, United States
H-Index Metrics
Total
Last 6 Years
Last 6 Years / Total
41
26
0.634
José Antonio Sacristán
Eli Lilly and Company
Indianapolis, United States
H-Index Metrics
Total
Last 6 Years
Last 6 Years / Total
41
20
0.488
Clinical research
patients
methodology
effectiveness
cost-effectiveness
Andrew C Adams
Eli Lilly and Company
Indianapolis, United States
H-Index Metrics
Total
Last 6 Years
Last 6 Years / Total
40
34
0.850
RNA
Oligonucleotides
Delivery of Novel Modalities
Virology
SARS-CoV-2
Klaus Gottlieb
Eli Lilly and Company
Indianapolis, United States
H-Index Metrics
Total
Last 6 Years
Last 6 Years / Total
37
23
0.622
James W Perfield Ii
Eli Lilly and Company
Indianapolis, United States
H-Index Metrics
Total
Last 6 Years
Last 6 Years / Total
35
23
0.657
Rebecca L Robinson
Eli Lilly and Company
Indianapolis, United States
H-Index Metrics
Total
Last 6 Years
Last 6 Years / Total
34
23
0.676
Zvonko Milicevic
Eli Lilly and Company
Indianapolis, United States
H-Index Metrics
Total
Last 6 Years
Last 6 Years / Total
33
25
0.758
Yaming Wang
Eli Lilly and Company
Indianapolis, United States
H-Index Metrics
Total
Last 6 Years
Last 6 Years / Total
32
25
0.781
innate immunity
neuroimmunology
neurodegneration
pathagen/damage associated molecular patterns
host-pathogen interaction
David Cox
Eli Lilly and Company
Indianapolis, United States
H-Index Metrics
Total
Last 6 Years
Last 6 Years / Total
32
14
0.438
Olivier Benichou
Eli Lilly and Company
Indianapolis, United States
H-Index Metrics
Total
Last 6 Years
Last 6 Years / Total
31
20
0.645
osteopetrosis
psoriatic arthritis
rheumatoid arthritis
muscle
osteoarthrtis
Robert W Siegel
Eli Lilly and Company
Indianapolis, United States
H-Index Metrics
Total
Last 6 Years
Last 6 Years / Total
31
18
0.581
Mathijs C Bunck
Eli Lilly and Company
Indianapolis, United States
H-Index Metrics
Total
Last 6 Years
Last 6 Years / Total
27
21
0.778
William Landschulz
Eli Lilly and Company
Indianapolis, United States
H-Index Metrics
Total
Last 6 Years
Last 6 Years / Total
27
18
0.667
Matthew Coghlan
Eli Lilly and Company
Indianapolis, United States
H-Index Metrics
Total
Last 6 Years
Last 6 Years / Total
27
18
0.667